Please Wait
Applying Filters...

Manufacturers & Suppliers of 4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 653Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AMN Life Science

02 3Ascent Innovative Medicines

03 3Intas Pharmaceuticals

04 3KMS Health Center Pvt. Ltd

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

01

2024 ISPE Annual Meeting
Not Confirmed
arrow

02

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

02

2024 ISPE Annual Meeting
Not Confirmed
arrow

03

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

03

2024 ISPE Annual Meeting
Not Confirmed
arrow

04

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

04

2024 ISPE Annual Meeting
Not Confirmed
arrow

05

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

05

2024 ISPE Annual Meeting
Not Confirmed
arrow

06

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

06

2024 ISPE Annual Meeting
Not Confirmed
arrow

07

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : SR Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

07

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : SR Tablet

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

08

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : SR Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

08

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : SR Tablet

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

09

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : SR Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

09

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : SR Tablet

Dosage Strength : 15MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

10

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

10

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : ER Tablet

Dosage Strength : 5MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

11

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 10MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

11

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : ER Tablet

Dosage Strength : 10MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank

12

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Brand Name :

Dosage Form : ER Tablet

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

12

2024 ISPE Annual Meeting
Not Confirmed
arrow
arrow
2024 ISPE Annual Meeting
Not Confirmed

Oxybutynin

Dosage : ER Tablet

Dosage Strength : 15MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

blank